Moderna

YTD

ALL

Trade Moderna 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics.

CEO

Stéphane Bancel

CEOStéphane Bancel

Employees

5,800

Employees5,800

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2010

Founded2010

Employees

5,800

Employees5,800

MRNA Key Statistics

Market cap

10.58B

Market cap10.58B

Price-Earnings ratio

-3.14

Price-Earnings ratio-3.14

Dividend yield

—

Dividend yield—

Average volume

11.80M

Average volume11.80M

High today

$27.93

High today$27.93

Low today

$26.86

Low today$26.86

Open price

$27.30

Open price$27.30

Volume

8.33M

Volume8.33M

52 Week high

$148.84

52 Week high$148.84

52 Week low

$23.15

52 Week low$23.15

MRNA News

Simply Wall St 18h

Moderna Insiders Added US$6.01m Of Stock To Their Holdings

In the last year, multiple insiders have substantially increased their holdings of Moderna, Inc. ( ) stock, indicating that insiders' optimism about the company...

Analyst ratings

64%

of 28 ratings

Buy

21.4%

Hold

64.3%

Sell

14.3%

People also own

Based on the portfolios of people who own MRNA. This list is generated using Robinhood data, and it’s not a recommendation.